VistaPharm announces launch of Potassium Chloride Solution

NewsGuard 100/100 Score
Dec 14 2015

VistaPharm today announced that it has launched Potassium Chloride Solution, USP, 10% in Unit Dose. The product is supplied to the market in a 50 count case of 30mL unit dose cups.

Potassium Chloride is indicated for the treatment and prophylaxis of hypokalemia in patients for whom dietary management with potassium-rich foods or diuretic dose reduction are insufficient.

VistaPharm recently has entered a definitive agreement to be acquired by Vertice Pharma (www.verticepharma.com), a specialty pharmaceuticals company based in NJ for an undisclosed amount and it is subject to customary closing conditions.

Source:

VistaPharm

Posted in: Pharmaceutical News

Tags: , , , , , , ,

Comments (0)

Suggested Reading

How do acetylsalicylic acid and warfarin interact with various nutrients?
Early legume intake linked to better nutrition in toddlers
Association between dietary thiamine consumption and cognitive decline
Exploring the health secrets of cucurbits: A closer look at Cucumis and Momordica
Are avocados good for your heart health?
Link between nutrient intake and multimorbidity risk reported in recent study, more research is needed
Balancing diets: study reveals plant protein's impact on nutrient levels in Americans
Eating nuts during pregnancy may lessen children's peer problems, study suggests

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
The global quest for the right balance of sodium and potassium in the diet